CytoSwitch -
LMU Department Pharmazie

 Employees: less than 10
CytoSwitch is an anticancer drug development spinoff project at the LMU Munich, currently based in the Thorn-Seshold group at the Department of Pharmacy.

We are an interdisciplinary team developing an exciting antimitotic compound that can selectively attack cancer tumours. Our first generation compound was published in Cell and highlighted in Cancer Discovery and The Economist. Our team has obtained several awards including the BioVaria Spinoff Award and the Flügge Spinoff Funding and in November 2016, we secured a large applied research grant from the BMBF to run in vivo preclinical testing for the next three years.

Application & Start your career

Way of application:
  • Apply via E-Mail
  • Online application


Value of employees: less than 10
Expansion: national

In our company employees are working in the following fields:
Clinical research, Other Activities, Project Management, Research & Development, Research & Education, Research Associate

In our company employees with these qualifications are welcome:
Pharmaceutics, Biology & Life Sciences, Chemistry, Veterinary Medicine, Biotechnology, Human Medicine


LMU Department Pharmazie
Butenandtstrasse 5-13
81377 München